# Different Dosage of Domestic and Imported Clopidogrel on the Platelet Inhibition Ratio in Patients Undergoing PCI

> **NCT03006835** · PHASE4 · UNKNOWN · sponsor: **Xijing Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Coronary Heart Disease

## Interventions

- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT03006835
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2016-12-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03006835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03006835, "Different Dosage of Domestic and Imported Clopidogrel on the Platelet Inhibition Ratio in Patients Undergoing PCI". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03006835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*